February 22nd 2024
Shortage in hepatitis b virus (HBV) clinical trials within the WHO African region.
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Hepatitis C Treatment to be Afforded to All Infected Veterans, Regardless of Stage of Disease
March 16th 2016An increase in funding from Congress, in addition to a decrease in drug prices, will allow the VA to finance medical care for all hepatitis C patients, regardless of the stage of the disease, for fiscal year 2016.
Read More
Malaria Diagnostic Test Safely Determines Infection During Ebola Outbreak
February 19th 2016Researchers from the National Institutes of Health found that PCR-based testing is the most effective diagnostic test to assist with case-patient management during Ebola virus outbreaks in malaria-endemic areas.
Read More
FDA Warns of Serious Slowing of Heart Rate with Hepatitis C Drugs and Amiodarone
May 30th 2015The FDA approved label warning changes for two Gilead Sciences hepatitis C drugs after one person died and nine others had serious reactions when the drugs were coadministered with amiodarone, a drug used to treat irregular heartbeat.
Read More
Reactivation of Hepatitis B Associated With Immunosuppressive Medications
May 30th 2015In patients with chronic HBV, the immune system may have very low levels of the virus. When reactivation occurs due to immunosuppression, these viruses begin to replicate again. Common symptoms of this event include inflammation of the liver and elevations of liver enzyme levels in the blood. In some cases, bilirubin levels may rise in response to reactivation of infection.
Read More
The US Department of Health and Human Services (HHS) plans to spend $2.7 billion in emergency funds to counter the spread of Ebola. Spending categories range from over a half billion dollars for international projects to a half million dollars for regulatory work that includes monitoring for fraudulent Ebola products.
Read More
Tenofovir Plus Interferon Improves Antigen Clearance in Chronic Hepatitis B
December 13th 2014Treatment with a combination of tenofovir and pegylated interferon yielded higher rates of hepatitis B surface antigen (HBsAg) loss than when either drug was used singly. Further, with longer therapy duration improved results.
Read More
Triple Therapy for Hepatitis C Infection: Bacterial Infection Risk Rises, Changes
December 1st 2014Patients who have HCV infection are at high risk for arthralgia, myalgias, pruritus, neuropathy, and decompensated livers. Until recently the sole available treatment was interferon. After the US Food and Drug Administration (FDA) approved ribavirin, patients who took ribavirin plus interferon responded better. Now, the FDA has approved a small selection of oral antivirals to treat hepatitis C.
Read More
CDC Provides More Answers About ZMapp
September 11th 2014Now that the two American patients infected with Ebola have arrived safely in Atlanta, the US Centers for Disease Control and Prevention has released more information about ZMapp, the experimental medication the patients were treated with before being flown back to the US.
Read More
Two Americans Infected with Ebola Virus Treated with the Experimental Medication ZMapp
September 10th 2014While hundreds of people have died in Africa from the latest outbreak of the Ebola virus, two infected Americans appear to be recovering after receiving doses of an experimental serum that has never been tested in human subjects
Read More
Recommendations to Improve Liver Health in Hepatitis B, Hepatitis C Patients
September 10th 2014Although it is widely understood that hepatitis B virus (HBV) and hepatitis C virus (HCV) are the leading causes of liver cirrhosis and liver cancer, an alarming number of HBV and HCV carriers have unhealthy habits that result in poor liver health.
Read More
Serious Liver Disease Rates Higher Among Coinfected Patients
June 19th 2014Study results show hepatic decompensation is more common in people who have both HIV and hepatitis C virus (HCV) compared to those infected only with HCV, an indication that early HCV treatment among coinfected patients is needed.
Read More